Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-17

Clinical Trial Update: Pre-operative Hypofractionated Proton Therapy [NA]

View source ↗

Summary

A clinical trial at Johns Hopkins is recruiting to evaluate pre-operative hypofractionated proton therapy for soft tissue sarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Soft Tissue Sarcoma | NA | Status: RECRUITING